146 related articles for article (PubMed ID: 36639836)
41. Primary Metabolism and Medium-Chain Fatty Acid Alterations Precede Long-Chain Fatty Acid Changes Impacting Neutral Lipid Metabolism in Response to an Anticancer Lysophosphatidylcholine Analogue in Yeast.
Tambellini NP; Zaremberg V; Krishnaiah S; Turner RJ; Weljie AM
J Proteome Res; 2017 Oct; 16(10):3741-3752. PubMed ID: 28849941
[TBL] [Abstract][Full Text] [Related]
42. Lysophosphatidylcholine enhances susceptibility in signaling pathway against pathogen infection through biphasic production of reactive oxygen species and ethylene in tobacco plants.
Wi SJ; Seo Sy; Cho K; Nam MH; Park KY
Phytochemistry; 2014 Aug; 104():48-59. PubMed ID: 24837357
[TBL] [Abstract][Full Text] [Related]
43. Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion.
Klett EL; Chen S; Edin ML; Li LO; Ilkayeva O; Zeldin DC; Newgard CB; Coleman RA
J Biol Chem; 2013 Jul; 288(30):21618-29. PubMed ID: 23766516
[TBL] [Abstract][Full Text] [Related]
44. Hydrocarbon chain length-dependent antagonism of acylcarnitines to the depressant effect of lysophosphatidylcholine on cardiac sodium current.
Sato T; Ishida H; Nakazawa H; Arita M
J Mol Cell Cardiol; 1996 Oct; 28(10):2183-94. PubMed ID: 8930813
[TBL] [Abstract][Full Text] [Related]
45. 17Beta-estradiol inhibits proliferation of cultured vascular smooth muscle cells induced by lysophosphatidylcholine via a nongenomic antioxidant mechanism.
Yoon BK; Oh WJ; Kessel B; Roh CR; Choi D; Lee JH; Kim DK
Menopause; 2001; 8(1):58-64. PubMed ID: 11201517
[TBL] [Abstract][Full Text] [Related]
46. The type 2 diabetes presumed causal variant within TCF7L2 resides in an element that controls the expression of ACSL5.
Xia Q; Chesi A; Manduchi E; Johnston BT; Lu S; Leonard ME; Parlin UW; Rappaport EF; Huang P; Wells AD; Blobel GA; Johnson ME; Grant SFA
Diabetologia; 2016 Nov; 59(11):2360-2368. PubMed ID: 27539148
[TBL] [Abstract][Full Text] [Related]
47. Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions.
Mashima T; Sato S; Sugimoto Y; Tsuruo T; Seimiya H
Oncogene; 2009 Jan; 28(1):9-19. PubMed ID: 18806831
[TBL] [Abstract][Full Text] [Related]
48. Benidipine, a dihydropyridine-calcium channel blocker, prevents lysophosphatidylcholine-induced injury and reactive oxygen species production in human aortic endothelial cells.
Matsubara M; Hasegawa K
Atherosclerosis; 2005 Jan; 178(1):57-66. PubMed ID: 15585201
[TBL] [Abstract][Full Text] [Related]
49. Very long-chain acyl-CoA synthetase 3: overexpression and growth dependence in lung cancer.
Pei Z; Fraisl P; Shi X; Gabrielson E; Forss-Petter S; Berger J; Watkins PA
PLoS One; 2013; 8(7):e69392. PubMed ID: 23936004
[TBL] [Abstract][Full Text] [Related]
50. Application of a diagnostic methodology by quantification of 26:0 lysophosphatidylcholine in dried blood spots for Japanese newborn screening of X-linked adrenoleukodystrophy.
Wu C; Iwamoto T; Igarashi J; Miyajima T; Hossain MA; Yanagisawa H; Akiyama K; Shintaku H; Eto Y
Mol Genet Metab Rep; 2017 Sep; 12():115-118. PubMed ID: 28725571
[TBL] [Abstract][Full Text] [Related]
51. Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy.
Ellis JM; Mentock SM; Depetrillo MA; Koves TR; Sen S; Watkins SM; Muoio DM; Cline GW; Taegtmeyer H; Shulman GI; Willis MS; Coleman RA
Mol Cell Biol; 2011 Mar; 31(6):1252-62. PubMed ID: 21245374
[TBL] [Abstract][Full Text] [Related]
52. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation.
Kugiyama K; Ohgushi M; Sugiyama S; Murohara T; Fukunaga K; Miyamoto E; Yasue H
Circ Res; 1992 Dec; 71(6):1422-8. PubMed ID: 1423937
[TBL] [Abstract][Full Text] [Related]
53. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
[TBL] [Abstract][Full Text] [Related]
54. Human intestinal acyl-CoA synthetase 5 is sensitive to the inhibitor triacsin C.
Kaemmerer E; Peuscher A; Reinartz A; Liedtke C; Weiskirchen R; Kopitz J; Gassler N
World J Gastroenterol; 2011 Nov; 17(44):4883-9. PubMed ID: 22171129
[TBL] [Abstract][Full Text] [Related]
55. Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.
Chen WC; Wang CY; Hung YH; Weng TY; Yen MC; Lai MD
PLoS One; 2016; 11(5):e0155660. PubMed ID: 27171439
[TBL] [Abstract][Full Text] [Related]
56. Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: an update.
Yan S; Yang XF; Liu HL; Fu N; Ouyang Y; Qing K
World J Gastroenterol; 2015 Mar; 21(12):3492-8. PubMed ID: 25834313
[TBL] [Abstract][Full Text] [Related]
57. Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis.
Hung ND; Kim MR; Sok DE
Br J Pharmacol; 2011 Mar; 162(5):1119-35. PubMed ID: 21091644
[TBL] [Abstract][Full Text] [Related]
58. Identification and biochemical characterization of five long-chain acyl-coenzyme A synthetases from the diatom Phaeodactylum tricornutum.
Guo X; Jiang M; Wan X; Hu C; Gong Y
Plant Physiol Biochem; 2014 Jan; 74():33-41. PubMed ID: 24257028
[TBL] [Abstract][Full Text] [Related]
59. Thermodynamic insights into an interaction between ACYL-CoA-BINDING PROTEIN2 and LYSOPHOSPHOLIPASE2 in
Miao R; Lung SC; Li X; Li XD; Chye ML
J Biol Chem; 2019 Apr; 294(16):6214-6226. PubMed ID: 30782848
[TBL] [Abstract][Full Text] [Related]
60. Measurement of Long-Chain Fatty Acyl-CoA Synthetase Activity.
Füllekrug J; Poppelreuther M
Methods Mol Biol; 2016; 1376():43-53. PubMed ID: 26552674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
